SCIENION and Applied Microarrays announce a strategic partnership to deliver next generation medical devices
SCIENION AG, a solution provider for precise liquid dispensing applications, and Applied Microarrays, Inc. the recognized leader in manufacturing services for multiplexed testing, today announced a strategic partnership to enable end-to-end solutions for the production of a wide range of multiplexed diagnostic devices.
Berlin, Germany, and Tempe, AZ, USA, JULY 28, 2016: SCIENION and Applied Microarrays will offer joint services and equipment solutions, that will allow our customers to support all aspects of development, high volume manufacturing and launch of regulated IVD products.
“Our objectives are to enable our customers to achieve rapid time-to-market, and to increase their probability of success related to scaling the production of diagnostic devices. This partnership will facilitate a seamless integration of developmental work carried out at both our companies.” SCIENION CEO Holger Eickhoff said.
“For us, working with the team at Applied Microarrays, means reaching a huge new audience of users who need affordable and effective tools to produce diagnostic devices. Many of our customers already work with both our companies. This partnership will enable those and future joint customers to interact and communicate seamlessly during development and manufacturing.” Eickhoff said.
“A key factor for the growth of Applied Microarrays business has been the extension of our services to manage additional steps in our customers product development and supply chains. Our partnership with SCIENION will further expand the range of leadership deposition technologies we can apply across existing and future customer application areas. We expect the new joint service offering to be extremely well received by our customers.” Applied Microarrays CEO Alastair Malcolm stated.
About Applied Microarrays
Applied Microarrays Inc. (AMI) is a company headquartered in Tempe, Arizona. Applied Microarrays designs, optimizes and manufactures custom DNA and protein microarrays in slide, microtiter plate, and custom lab-on-chip formats. AMI operates under ISO 9001 and 13485 certification, and since acquiring GE Healthcare’s microarray business in 2007 has evolved from custom array printing to offering full end- to-end solutions for RUO and regulated Dx multiplex devices for customers worldwide.
SCIENION offers complete solutions for precise liquid dispensing applications enabling high throughput production of multiparameter assays in diagnostics, and life and material sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION offers a unique technology portfolio that has been continuously expanded for over 15 years. SCIENION provides flexible solutions for
research and development, wherein solutions for production purposes are customized. Systems and software are characterized by their versatility, precision and robustness. The company is a renowned specialist for ultra-low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. SCIENION’s dispensers allow for contact-free and precise drop spotting in the pico- to micro-liter range and are optimally suited for microarray based analytics – such as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various substrates. The company operates from two sites in Germany, Dortmund and Berlin, and has a subsidiary in New Jersey, USA.
Applied Microarrays Inc.
7700 S. River Parkway
Tempe, AZ 85284, USA
Phone +1 480 775 6320 x2312 firstname.lastname@example.org ww.appliedmicroarrays.com
Almut Gebhard Otto-Hahn-Str. 15
Phone +49 (0)30 – 6392 1700 Fax +49 (0)30 – 6392 1701 email@example.com www.scienion.com